Beta-catenin gene alteration in glandular stomach adenocarcinomas in N-methyl-N-nitrosourea-treated and Helicobacter pylori-infected Mongolian gerbils - PubMed (original) (raw)

Beta-catenin gene alteration in glandular stomach adenocarcinomas in N-methyl-N-nitrosourea-treated and Helicobacter pylori-infected Mongolian gerbils

Xueyuan Cao et al. Cancer Sci. 2004 Jun.

Erratum in

Abstract

The goal of this study was to elucidate whether beta-catenin gene mutations might contribute to glandular stomach carcinogenesis in Helicobacter pylori (H.pylori)-infected Mongolian gerbils. Firstly, exon 3 of gerbil beta-catenin cDNA, a mutation hot spot, was cloned and sequenced and found to have 89.3% homology with the human form and 95.5% with the rat and mouse forms. Peptide sequence in this region was shown to be 100% conserved in these mammals. Then, 45 stomach adenocarcinomas induced with N-methyl-N-nitrosourea (MNU) plus H. pylori infection and 7 induced with MNU alone were examined for beta-catenin expression by immunohistochemistry and for DNA mutations using a combination of microdissection and PCR-single strand conformation polymorphism analysis. One gastric cancer in the MNU + H. pylori group (2.2%) displayed nuclear (N) beta-catenin localization, 3 (6.7%) showed cytoplasmic (C) distribution in local regions, and 41 (91.1%) demonstrated cell membrane (M) localization. Tumors induced by MNU alone showed only membranous beta-catenin localization (7/7). Analysis of exon 3 of the beta-catenin gene dem-onstrated all tumors with membrane or cytoplasmic staining as well as surrounding normal mucosa (S) to feature wild-type beta-catenin. In contrast, the lesion with nuclear staining had a missense mutation at codon 34 [GAC (Gly) --> GAA (Glu)] in exon 3 (1/1 = 100%, N vs. M, P < 0.05; and N vs. S, P < 0.05). In conclusion, these results suggest that beta-catenin may not be a frequent target for mutation in stomach carcinogenesis in MNU + H. pylori-treated gerbils.

PubMed Disclaimer

References

    1. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E‐Cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402–5. -PubMed
    1. Shimoyama Y, Hirohashi, S. Expression of E‐ and P‐cadherin in gastric carcinomas. Cancer Res 1991; 51: 2185–92. -PubMed
    1. Candidas S, Bischoff P, Becker KF, Hofler H. No evidence for mutations in the alpha‐ and beta‐catenin genes in human gastric and breast carcinomas. Cancer Res 1996; 56: 49–52. -PubMed
    1. Woo DK, Kim HS, Lee HS, Rang YH, Yang HK, Kim WH. Altered expression and mutation of beta‐catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001; 95: 108–13. -PubMed
    1. Tong JH, To KF, Ng EK, Lau JY, Lee TL, Lo KW, Leung WK, Tang NL, Chan FK, Sung JJ, Chung SC. Somatic beta‐catenin mutation in gastric car‐cinoma‐an infrequent event that is not specific for microsatellite instability. Cancer Lett 2001; 163: 125–30. -PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources